AAAAAA
Results: 1-25/34
Authors:
Judson, I
Radford, JA
Harris, M
Blay, JY
van Hoesel, Q
le Cesne, A
van Oosterom, AT
Clemons, MJ
Kamby, C
Hermans, C
Whittaker, J
di Paola, ED
Verweij, J
Nielsen, S
Citation: I. Judson et al., Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL (R)/CAELYX (R)) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group, EUR J CANC, 37(7), 2001, pp. 870-877
Authors:
Flechon, A
Lombard-Bohas, C
Boulez, J
Blay, JY
Scoazec, JY
Citation: A. Flechon et al., Complete response of an HIV negative gastric Kaposi's sarcoma (KS) patientwith peritoneal carcinomatosis by liposomal daunorubicin treatment, ANN ONCOL, 12(2), 2001, pp. 275-276
Authors:
Reni, M
Ferreri, AJM
Guha-Thakurta, N
Blay, JY
Dell'Oro, S
Biron, P
Hochberg, FH
Citation: M. Reni et al., Clinical relevance of consolidation radiotherapy and other main therapeutic issues in primary central nervous system lymphomas treated with upfront high-dose methotrexate, INT J RAD O, 51(2), 2001, pp. 419-425
Authors:
Menetrier-Caux, C
Thomachot, MC
Alberti, L
Montmain, G
Blay, JY
Citation: C. Menetrier-caux et al., IL-4 prevents the blockade of dendritic cell differentiation induced by tumor cells, CANCER RES, 61(7), 2001, pp. 3096-3104
Authors:
Bay, JO
Blay, JY
Citation: Jo. Bay et Jy. Blay, High-dose chemotherapy for tumor treatment: the end of the beginning?, B CANCER, 88(9), 2001, pp. 821-821
Authors:
Roy-Coquard, I
Biron, P
Blay, JY
Citation: I. Roy-coquard et al., High-dose chemotherapy in soft tissue sarcomas of adults, B CANCER, 88(9), 2001, pp. 858-862
Authors:
Ray-Coquard, I
Le Cesne, A
Blay, JY
Citation: I. Ray-coquard et al., STI571 and gastro intestinal stromal tumors, B CANCER, 88(7), 2001, pp. 661-662
Authors:
Soussi, T
Gisselbrecht, S
Blay, JY
Citation: T. Soussi et al., c-Kit, SCFR (stem cell factor receptor) CD117, B CANCER, 88(10), 2001, pp. 939-940
Authors:
Ray-Coquard, I
Ghesquiere, H
Bachelot, T
Borg, C
Biron, P
Sebban, C
LeCesne, A
Chauvin, F
Blay, JY
Citation: I. Ray-coquard et al., Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas, BR J CANC, 85(6), 2001, pp. 816-822
Authors:
Philip, T
Blay, JY
Brunat-Mentigny, M
Carrie, C
Chauvot, P
Farsi, F
Fervers, B
Gentet, JC
Giammarile, F
Kohler, R
Mathoulin, S
Patricot, LM
Thiesse, P
Citation: T. Philip et al., Osteosarcoma, BR J CANC, 84, 2001, pp. 78-80
Authors:
Voog, E
Sebban, C
Biron, P
Philip, T
Blay, JY
Citation: E. Voog et al., A prospective study of the LMB regimen for diffuse large cell non Hodgkin's lymphoma in adults, LEUK LYMPH, 36(5-6), 2000, pp. 525-532
Authors:
Nielsen, OS
Judson, I
van Hoesel, Q
le Cesne, A
Keizer, HJ
Blay, JY
van Oosterom, A
Radford, JA
Svancarova, L
Krzemienlecki, K
Hermans, C
van Glabbeke, M
Oosterhuis, JW
Verweij, J
Citation: Os. Nielsen et al., Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group, EUR J CANC, 36(1), 2000, pp. 61-67
Authors:
Biron, P
Sebban, C
Gourmet, R
Chvetzoff, G
Philip, I
Blay, JY
Citation: P. Biron et al., Research controversies in management of oral mucositis, SUPP CARE C, 8(1), 2000, pp. 68-71
Authors:
Blay, JY
Ongolo-Zogo, P
Sebban, C
Carrie, C
Thiesse, P
Biron, P
Citation: Jy. Blay et al., Primary cerebral lymphomas: Unsolved issues regarding first-line treatment, follow-up, late neurological toxicity and treatment of relapses, ANN ONCOL, 11, 2000, pp. 39-44
Authors:
Blay, JY
Citation: Jy. Blay, Use of hematopoietic growth factors in cancerology, PRESSE MED, 29(36), 2000, pp. 1984-1986
Authors:
Blay, JY
Le Cesne, A
Blanc-Vincent, MP
Fervers, B
Latour, JF
Philip, T
Citation: Jy. Blay et al., Standards, Options and Recommendations for the use of hematopoietic growthfactors in cancerology, PRESSE MED, 29(36), 2000, pp. 2004-2008
Authors:
Blay, JY
Bouhour, D
Ray-Coquard, I
Dumontet, C
Philip, T
Biron, P
Citation: Jy. Blay et al., High-dose chemotherapy with autologous hematopoietic stem-cell transplantation for advanced soft tissue sarcoma in adults, J CL ONCOL, 18(21), 2000, pp. 3643-3650
Authors:
Le Cesne, A
Judson, I
Crowther, D
Rodenhuis, S
Keizer, HJ
Van Hoesel, Q
Blay, JY
Frisch, J
Van Glabbeke, M
Hermans, C
Van Oosterom, A
Tursz, T
Verweij, J
Citation: A. Le Cesne et al., Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group, J CL ONCOL, 18(14), 2000, pp. 2676-2684
Authors:
Casasnovas, RO
Haioun, C
Dumontet, C
Gabarre, J
Richard, B
Lederlin, P
Caillot, D
Stamatoullas, A
Morel, P
Quesnel, B
Blay, JY
Bouabdallah, K
Gisselbrecht, C
Citation: Ro. Casasnovas et al., Phase II study of 3-hour infusion of high dose paclitaxel in refractory and relapsed aggressive non-Hodgkin's lymphomas, HAEMATOLOG, 85(5), 2000, pp. 502-507
Authors:
Blay, JY
Thomachot, MC
Alberti, L
Bachelot, T
Voorzanger-Rousselot, N
Puisieux, I
Odin, L
Menetrier-Caux, C
Citation: Jy. Blay et al., Immunotherapy of cancers - New approaches, B CANCER, 87(1), 2000, pp. 97-106
Authors:
Blay, JY
Judson, I
Rodenhuis, S
Hermans, C
Smith, M
van Glabbeke, M
Verweij, J
Citation: Jy. Blay et al., Phase II study of raltitrexed ('Tomudex') for patients with advanced soft tissue sarcomas refractory to doxorubicin-containing regimens, ANTI-CANC D, 10(10), 1999, pp. 873-877
Authors:
Ongolo-Zogo, P
Thiesse, P
Sau, J
Desuzinges, C
Blay, JY
Bonmartin, A
Bochu, M
Philip, T
Citation: P. Ongolo-zogo et al., Assessment of osteosarcoma response to neoadjuvant chemotherapy: comparative usefulness of dynamic gadolinium-enhanced spin-echo magnetic resonance imaging and technetium-99m skeletal angioscintigraphy, EUR RADIOL, 9(5), 1999, pp. 907-914
Authors:
Philip, T
Iliescu, C
Demaille, MC
Pacquement, H
Gentet, JC
Krakowski, I
Soler-Michel, P
Thiesse, P
Chauvin, F
Blay, JY
Brunat-Mentigny, M
Citation: T. Philip et al., High-dose methotrexate and HELP [Holoxan (ifosfamide), Eldesine (vindesine), platinum] - doxorubicin in non-metastatic osteosarcoma of the extremity:A French multicentre pilot study, ANN ONCOL, 10(9), 1999, pp. 1065-1071
Authors:
Ray-Coquard, I
Le Cesne, A
Rubio, MT
Mermet, J
Maugard, C
Ravaud, A
Chevreau, C
Sebban, C
Bachelot, T
Biron, P
Blay, JY
Citation: I. Ray-coquard et al., Risk model for severe anemia requiring red blood cell transfusion after cytotoxic conventional chemotherapy regimens, J CL ONCOL, 17(9), 1999, pp. 2840-2846
Authors:
Voog, E
Biron, P
Martin, JP
Blay, JY
Citation: E. Voog et al., Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma, CANCER, 85(12), 1999, pp. 2589-2595